| JXSL1900075 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Import Drug Application | 2019-09-07 | | Eli Lilly & Company | In Review | 2019-09-06 | view |
| JYSB2200179 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2022-09-19 | | Eli Lilly & Company | | | view |
| JYSB2000514 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2020-10-15 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2021-01-05 | view |
| JXSS2101023 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-23 | | | | | view |
| JYSB2000378 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | Eli Lilly and Company | Eli Lilly & Company | Filed | 2020-09-02 | view |
| JYSB2101031 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2021-05-17 | | Eli Lilly & Company | | | view |
| JYSB2000243 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2020-06-10 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Filed | 2020-06-19 | view |
| JYSZ2300053 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | License Renew | 2023-12-16 | | | | | view |
| JYSB2000131 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2020-04-16 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia | Filed | 2020-04-23 | view |
| JYSB2300129 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2023-08-11 | | Eli Lilly & Company | | | view |
| JYSB2200159 | 依奇珠单抗注射液 | ixekizumab | Injection | Biological Products | Supplementary Application | 2022-08-17 | | Eli Lilly & Company | | | view |
